InMode
21084 Bake Parkway
Suite 106
Lake Forest
California
92630
United States
Tel: 855-411-2639
Website: http://inmodemd.com/
Email: info@inmodemd.com
About InMode
InMode's technology advancements is the new gold standard for aesthetic medicine. Two decades ago our R&D team were critical in developing state-of-the-art light, laser, and radiofrequency devices, thereby launching and shaping the industry. Our technology continues that legacy in providing superior satisfaction for both the patient and the practice. InMode has revolutionary non-invasive options for fractional skin treatment and contraction (Fractora), skin tightening (Forma&Plus), ultra-fast diode hair removal (Diolaze), peak power photofacial for skin pigmentation and vascular lesions (Lumecca), and cellulite reduction/body contouring (BodyFX).LEADERSHIP:
CEO: Erik Dowell
PRODUCTS:
All Products
FOLLOW InMode:
Tweets by Inmode
77 articles about InMode
-
InMode Responds To BTL Petition for Inter Partes Review Of Patent InMode Is Asserting Against BTL
4/15/2024
InMode Ltd., a leading global provider of innovative medical technologies, responded to the recent petition to the U.S. Patent & Trademark Office filed by BTL Industries, Inc., in which BTL asks the USPTO to conduct an Inter Partes Review of InMode's U.S. Patent No. 8,961,511.
-
InMode to Report First Quarter 2024 Financial Results and Hold Conference Call May 2, 2024
4/9/2024
InMode Ltd. announced today that it expects to release its financial results for the first quarter of 2024 before the Nasdaq market opens on Thursday, May 2, 2024.
-
InMode to Present at Upcoming Investor Conferences and Events - April 3, 2024
4/3/2024
InMode Ltd. today announced the participation at the following investor conferences and events in April and May.
-
InMode to Present at March Investor Conferences and Events
3/4/2024
InMode Ltd. today announced the participation at the following investor conferences and events in March.
-
InMode Reports Fourth Quarter and Full Year 2023 Financial Results; Quarterly Revenue of $126.8M and Record Full Year Revenue of $492M
2/13/2024
InMode Ltd., a leading global provider of innovative medical technologies, announced its consolidated financial results for the fourth quarter and full year ended December 31, 2023.
-
InMode to Report Fourth Quarter & Full Year 2023 Financial Results and Hold Conference Call on Feb. 13, 2024
1/16/2024
InMode Ltd. announced today that it expects to release its financial results for the fourth quarter and full year 2023 before the Nasdaq market opens on Tuesday, February 13, 2024.
-
InMode to Present at Upcoming Investor Conferences and Events - November 6, 2023
11/6/2023
InMode Ltd. today announced the participation at the following investor conferences and events in November and December.
-
InMode Reports Third Quarter 2023 Financial Results; Quarterly Revenue of $123.1M Represents 2% Year-Over-Year Growth
11/2/2023
InMode Ltd., a leading global provider of innovative medical technologies, announced its consolidated financial results for the third quarter ended September 30, 2023.
-
InMode Expects Third Quarter 2023 Revenue Between $122.8M-$123.0M, Lowering Full-Year 2023 Revenue Guidance to $500M-$510M vs. Original Estimates of $530M-$540M
10/12/2023
InMode Ltd., a leading global provider of innovative medical technologies, announced that it expects to release its financial results for the third quarter of 2023 before the Nasdaq market opens on Thursday, Nov. 2, 2023.
-
InMode to Present at Upcoming September 2023 Investor Conferences and Events
9/5/2023
InMode Ltd., a leading global provider of innovative medical technologies, announced the participation at the following investor conferences and events in September.
-
InMode to Present at Upcoming Investor Conferences and Events - August 1, 2023
8/1/2023
InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced that InMode will participate at the following investor conferences and events in August.
-
InMode Reports Second Quarter 2023 Financial Results; Record Quarterly Revenue of $136.1M Represents 20% Year-Over-Year Growth
7/27/2023
InMode Ltd. today announced its consolidated financial results for the second quarter ended June 30, 2023.
-
InMode Expects Second Quarter 2023 Revenue Between $135.7-$135.9M, Increases Full Year 2023 Guidance, Expects Revenues of $530-540M
7/12/2023
Conference call to be held on Thursday, July 27, 2023, at 8:30 a.m. Eastern Time.
-
InMode to Present at Upcoming Investor Conferences and Events
5/17/2023
InMode Ltd. today announced that InMode will participate at the following investor conferences and events.
-
InMode Expects First Quarter 2023 Revenue Between $105.7-$105.9M, Non-GAAP Earnings per Diluted Share Between $0.50-$0.51
4/12/2023
InMode Ltd., a leading global provider of innovative medical technologies, announced that it expects to release its financial results for the first quarter of 2023 before the Nasdaq market opens on Tuesday, May 2, 2023.
-
InMode Updates It Does Not Hold Cash Deposits at SVB
3/13/2023
InMode Ltd., a leading global provider of innovative medical technologies, announced that that it does not hold cash deposits or securities at Silicon Valley Bank.
-
InMode to Present In-Person at the Barclays Global Health Conference
3/2/2023
InMode Ltd. (Nasdaq: INMD) , a leading global provider of innovative medical technologies, today announced that Yair Malca , Chief Financial Officer and Spero Theodorou MD, Chief Medical Officer, will present in-person at the Barclays Global Health Conference in Miami on March 15, 2023.
-
InMode Expects Record Fourth Quarter & Full Year 2022 Financial Results, Q4 Revenue Between $133.2M-$133.4M
1/11/2023
InMode Ltd. announced today that it expects to release its financial results for the fourth quarter and full year 2022 before the Nasdaq market opens on Tuesday, February 14, 2023.
-
InMode to Present at the 25th Annual Needham Growth Conference
1/3/2023
InMode Ltd. today announced that Moshe Mizrahy , Chairman and Chief Executive Officer, Yair Malca , Chief Financial Officer and Spero Theodorou MD, Chief Medical Officer, will present virtually at the 25th Annual Needham Growth Conference on Jan. 12, 2023.
-
InMode to Present at Upcoming Investor Conferences Before the End of 2022
11/1/2022
InMode Ltd., a leading global provider of innovative medical technologies, announced that InMode will present at the following investor conferences in November.